MarketResearchFuture.com adds “Cancer Immunotherapy Market -2018 Asia Pacific Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.
“Asia Pacific Cancer Immunotherapy Market by Manufacturers, Countries, Type and Application, Forecast to 2023 Report “Provides In-Depth Analysis of Parent Market Trends, Macro-Economic Indicators and Governing Factors Along With Market Attractiveness as Per Segments. Asia Pacific immunotherapy market is expecting a sound growth of CAGR of 15.5% during the forecasted period 2017-2023.
Market Scenario of Asia Pacific Cancer Immunotherapy Market:
Cancer is condition of uncontrolled cell growth. It is one of the deadliest disease in the world and the second major cause for death. Cancer can be defined as an abnormal cell growth with the potential to spread to other part of the body. There are over 100 types of cancer which has affected human. According to survey carried out by Pfizer, in 2012, 6.7 million of cancer cases was registered in Asia Pacific region which will increasing continuously. Additionally, according to the American Cancer Society, in 2015, 4.2 newly diagnosed invasive cancer cases were registered in China. During last decade, there is a significant increase in the number of patients suffering from different types of cancer. Smoking is one of the most risk factor for the cause of the cancer. Due to deteriorating lifestyle, smoking, and alcoholism there is a rise in the incident of cancer. Increasing cancer population is the major reason for increasing the Asia Pacific immunotherapy market. Different treatment are available in the market but the advantage of immunotherapy is its high effectiveness compare with other therapy. This therapy is effective for patient suffering from melanoma cancer where chemotherapy and other radiation therapy did not work. Increasing government support for research & development and increasing healthcare expenditure have fuelled the market growth. However, side effect of the treatments and high cost of the therapy may slow the market growth during the forecasted period.
Key Players in the Asia Pacific Cancer Immunotherapy Market:
The key players for the market are Amgen, Inc. (US), Bristol-Myers Squibb Company (US), Eli Lilly and Company (US), AstraZeneca Plc. (UK), GlaxoSmithKline Plc. (UK), Bayer AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Spectrum Pharmaceuticals Inc. (US), Janssen Biotech, Inc. (US), Sanofi (France), AbbVie Inc. (US), Takeda Pharmaceuticals (Japan), Oncomed Pharmaceuticals (US) and Immunomedics (US)
Segmentation of Asia Pacific Cancer Immunotherapy Market:
Asia Pacific cancer immunotherapy market is segmented on the basis of type of therapy, application and end users.
On the basis of type of therapy, the market is segmented into monoclonal antibodies, cancer vaccines, immunomodulators and other.
On the basis of application the market is segmented as lung cancer, blood cancer, melanoma, breast cancer and other.
On the basis of end user, the market is segmented into hospitals & clinics, research laboratories, cancer institute and others.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/639 .
Regional Analysis of Asia Pacific Cancer Immunotherapy Market:
Asia Pacific cancer immunotherapy market is segmented into Japan, China, India, Australia, Republic of Korea and Rest of Asia Pacific. The major driving factor for the market is increasing number of patient population in India and China. China and India are the major contributor in the Asia Pacific cancer immunotherapy market. According to the NCIP, 0.33 million of the people in India are suffering from cancer and the number is continuously increasing owing to the changing lifestyle. Moreover, presence of huge patient population and increasing government support for research & development will fuel the growth of the market in India. China holds the second largest market for cancer immunotherapy market which is followed by Japan. Increasing government support, rapidly developing economy and increasing healthcare expenditure will boost the growth of China and Japan market. Moreover, availability of highly skilled healthcare professionals and rising acceptance of these therapies and increasing demand for the treatment have provided push for the growth of the market in these countries. Australia and Rest of Asia Pacific contribute the least share in the market.
Major TOC of Asia Pacific Cancer Immunotherapy Market:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Asia Pacific Cancer Immunotherapy Market, By Type Of Therapy
Chapter 7. Asia Pacific Cancer Immunotherapy Market, By Application
Chapter 8. Asia Pacific Cancer Immunotherapy Market, By End User
Chapter 9. Asia Pacific Cancer Immunotherapy Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. Conclusion
Chapter 13. Appendix
LIST OF TABLES
Table 1 Cancer Immunotherapy Industry Synopsis, 2017 – 2023
Table 2 Asia Pacific Cancer Immunotherapy Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Asia Pacific Cancer Immunotherapy Market By Region, 2017 – 2023, (USD Million)
Table 4 Asia Pacific Cancer Immunotherapy Market By Types Of Therapy, 2017 – 2023, (USD Million)
Table 5 Asia Pacific Cancer Immunotherapy Market By Application, 2017 – 2023, (USD Million)
Table 6 Asia Pacific Cancer Immunotherapy Market By End Users, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Asia Pacific Cancer Immunotherapy Market
Figure 3 Segmentation Market Dynamics For Asia Pacific Cancer Immunotherapy Market
Figure 4 Asia Pacific Cancer Immunotherapy Market Share, By Product 2016
Figure 5 Asia Pacific Cancer Immunotherapy Market Share, By Application 2016
Figure 6 Asia Pacific Cancer Immunotherapy Market Share, By End Users, 2016
…CONTINUED
GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/639 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/asia-pacific-cancer-immunotherapy-market-639